Skip to content

BRVEBRAVEHEART BIO INC

CUSIP 10567X101 · common stock

2 tracked investors held BRAVEHEART BIO INC (BRVE) at the end of Q3 2026, worth $13.7M in total. The largest holder was RA Capital Management, with 0.1% of its portfolio. 2 investors opened new positions this quarter, including RA Capital Management.

Holders · Q3 2026
2
New holders
2
Value held
$13.7M
Quarter-end price (est.)
$20.20

Investors holding BRVE · Q3 2026

InvestorWeightSharesValueChange
RA Capital Management
RA Capital Management, L.P.
0.11%565,000$11.4MNEW
Perceptive Advisors
Perceptive Advisors LLC
0.04%115,000$2.3MNEW

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026220$13.7M$20.20